allogeneic hematopoietic stem cell transplant

October 31, 2017

Health Canada OKs Imbruvica for Treating Chronic Graft-Versus-Host Disease

News

Janssen‘s Imbruvica (ibrutinib) has been approved by Health Canada for treating chronic graft-versus-host disease (cGVHD), a life-threatening condition that some patients develop after a stem cell transplant. Following a priority ... Read more

March 28, 2017March 28, 2017

BL-8040 Is Effective at Mobilizing Bone Marrow Cells for Transplant, Clinical Trial Shows

News

A single injection of BL-8040 is as efficient at mobilizing bone marrow cells for transplant as the current standard of care — four to six injections of a protein called granulocyte-colony ... Read more

March 8, 2017March 8, 2017

Opdivo May Treat Hodgkin Lymphoma Patients Who Relapse After Stem Cell Transplant

News

The immune checkpoint inhibitor Opdivo (nivolumab) may induce remission in classical Hodgkin lymphoma (cHL) patients who have relapsed following an allogeneic hematopoietic stem cell transplant. That was the conclusion of a new ... Read more

August 30, 2016August 30, 2016

Adcetris May Improve or Cure Certain Hodgkin’s Lymphoma Patients After Failed Bone Marrow Transplant, Study Shows

News

Patients with Hodgkin’s lymphoma who failed to respond to autologous hematopoietic stem cell transplant (HSCT) may markedly benefit from Adcetris (brentuximab vedotin), according to end-of-study results of a Phase 2 ... Read more

August 17, 2016August 17, 2016

Side Effects of Bone Marrow Transplant Reduced by Expanding Regulatory T-Cells in Mouse Study

News

Researchers at the University Hospital Würzburg in Germany have come up with a new approach that prevents graft-versus-host disease (GvHD) from developing in animal models of bone marrow transplants. The study, “Exogenous ... Read more